Corbus Pharmaceuticals Holdings, Inc.
CRBP
$10.09
$0.010.10%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 57.30% | 7.68% | |||
| Gross Profit | -57.30% | -7.68% | |||
| SG&A Expenses | 11.82% | 25.98% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 48.91% | 10.64% | |||
| Operating Income | -48.91% | -10.64% | |||
| Income Before Tax | -52.54% | -11.74% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -52.54% | -11.74% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -52.54% | -11.74% | |||
| EBIT | -48.91% | -10.64% | |||
| EBITDA | -49.00% | -10.67% | |||
| EPS Basic | -47.02% | 1.54% | |||
| Normalized Basic EPS | -47.03% | 6.54% | |||
| EPS Diluted | -47.02% | 1.54% | |||
| Normalized Diluted EPS | -47.03% | 6.54% | |||
| Average Basic Shares Outstanding | 3.75% | 13.49% | |||
| Average Diluted Shares Outstanding | 3.75% | 13.49% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||